Diabetes is one of the most serious challenges to healthcare worldwide and is projected to affect 239 million people by the year 2010. It also represents the most common cause of progressive and disabling neuropathy in the world. A significant breakthrough in the treatment and/or management of diabetic peripheral neuropathy (DPN), therefore, represents an opportunity to reduce the burden to society and improve the quality of life of people with diabetes. This text focuses on this complex subject, presenting the findings of the 8th meeting of the European Neurological Society, held in Nice, France in 1998. It discusses a drug that provides a possibility for a putative therapy for complications in diabetes, encouraging the investigation of its effects on disabling neuropathies characterized by small-fibre lesions.
Book Description
Product Details
Would you like to update product info or give feedback on images?
|
Customer Reviews
|
There are no customer reviews yet.
|
|||
|
Video reviews
|
Tag this product(What's this?)Think of a tag as a keyword or label you consider is strongly related to this product.
Tags will help all customers organize and find favorite items. |
Sell a Digital Version of This Book in the Kindle Store
If you are a publisher or author and hold the digital rights to a book, you can sell a digital version of it in our Kindle Store.
Learn more
Customer Discussions
|
This product's forum
Active discussions in related forums
Search Customer Discussions
|
Related forums
|
